IFN-γ and the gene signatures activated by IFN-γ signaling are associated with the best patient outcomes, anti-tumor immunity, and immunotherapy responses (8, 23, 95) and are regulated by miRNAs. The gene discussed is IFNG; the disease is neoplasm.